Article Listing - Janssen withdraws EU application for Invega

STERLING WINTHROP

10 February 1992

Sterling Winthrop has named Christopher Coughlin as chief financial officer, succeeding George Benjamin, who has retired.

CYTOTHERAPEUTICS

10 February 1992

Thomas Wiggans has been named as chief operating officer of Cytotherapeutics.

ASTRA/T CELL SCIENCES DEAL

10 February 1992

Astra of Sweden and T Cell Sciences in the USA have concluded the agreement first set up last year (Marketletter...

UPJOHN'S HALCION

10 February 1992

Shareholders of the US pharmaceutical concern Upjohn (see also page 4) have filed a lawsuit which accuses the company's senior...

ROMANIAN MEDICINES TO RUSSIA

10 February 1992

Romania is to export unspecified quantities of medicines and drugs to the Russian Federation this year, following the signing of...

UK DRUG STOCKS BULL RUN OVER?

10 February 1992

The performance of stocks in the UK's Health and Household sector, after a strong start to the New Year, came...

US APPROVAL FOR WELLCOME'S MIVACRON

10 February 1992

The US Food and Drug Administr-ation has granted marketing approval for Burroughs Wellcome's Mivacron (mivacurium chloride) to be used as...

OTC PRODUCTS IN EIRE

10 February 1992

The market for over-the-counter medicinal products in Ireland reached a value of almost IRL39 million ($65 million) last year. This...

FOURNIER PLANS GROWTH ABROAD

10 February 1992

French pharmaceutical group, Laboratoire Fournier, is planning foreign expansion following its failure to acquire Delagrange, which was finally acquired by...

CALCITRIOL BENEFIT FOR OSTEOPOROSIS

10 February 1992

Favorable results from a study involving Hoffmann-La Roche's calcitriol have been published by a New Zealand group led by Murray...

Showing 94761-94770 of 95316 articles